抗菌原药用于克服细菌对抗菌素的耐药性
Catarina Maria1, Ana M de Matos1, Amélia P Rauter1
1Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal.
Pharmaceuticals (Basel, Switzerland)
|June 27, 2024
概括
抗菌素耐药性 (AMR) 威胁全球健康,耐药细菌正在迅速发展. 本综述探讨了新的抗菌前药物策略,包括药物重新定位和纳米技术,以应对这种日益严重的危机.
科学领域:
- 微生物学与传染病的研究
- 药理学和药物发现
- 生物技术是生物技术.
背景情况:
- 抗菌素耐药性 (AMR) 是一个重大的全球健康威胁,由细菌进化和多药耐药菌株的出现驱动.
- 预计到2050年每年AMR死亡人数将达到1000万,这凸显了对新的治疗干预措施的迫切需要.
- 现有的治疗方法越来越无效,需要开发具有独特作用机制的新药.
研究的目的:
- 为了解决抗微生物药物耐药性的最新进展提供全面的概述.
- 突出抗菌前药物方法的潜力,作为克服AMR的战略.
- 综合2021年至2023年在抗菌素耐药性领域的关键研究成果.
主要方法:
- 审查2021年至2023年间发表的最新科学文献,重点关注抗菌素耐药性和新型治疗策略.
- 对研究的分析,包括用于抗菌应用的药物重新定位和衍生.
- 检查涉及纳米技术和自然产品在抗菌剂开发中的研究.
主要成果:
- 抗菌前药物方法,包括药物重用,衍生,纳米技术和天然产品探索,显示出显著的前景.
- 细菌中新兴的耐药机制需要创新的治疗解决方案.
- 最近的研究表明,人们越来越关注开发具有新型作用模式的药物来对抗耐药菌株.
结论:
- 抗菌前药物战略为开发针对抗菌素耐药性的新疗法提供了一个有希望的途径.
- 在药物再利用,纳米技术和天然产品领域的持续研究和开发对于解决AMR危机至关重要.
- 迫切需要全球关注和投资,以应对抗微生物药物耐药性不断升级的威胁.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Antimicrobial Proteins
975
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
975
Antibiotic Selection
53.0K
Overview
53.0K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K


